Acute Pain Clinical Trials

Find Acute Pain Clinical Trials Near You

A Novel Intervention for Avoidance-Related Opioid Misuse in Patients With Cancer

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This research study is being done to develop an intervention for psychological symptoms that patients diagnosed with cancer may experience. Psychological symptoms may include thoughts, feelings, emotions, and memories The names of the study intervention and research activities involved in this study are/is: * Acceptance \& Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist) * Questionnaires * Post-study interview Consistent with the NIH Stage Model for Behavioral Intervention Development, the investigators have adapted an existing, empirically-validated intervention, Acceptance and Commitment Therapy (ACT), to address substance use disorder risk during cancer care. The core components of ACT are particularly well-suited to address the psychological processes underlying opioid misuse in individuals treated for cancer pain. The overarching aim is to assess the feasibility and acceptability of the intervention by conducting a randomized pilot trial of the revised intervention (ACTION) for cancer patients on opioid therapy, and at risk for SUD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• at least 18 years old

• have an estimated survival time of at least 6 months (as estimated by palliative care provider)

• score at least 4 on the Opioid Risk Tool (ORT)

• have been diagnosed with any cancer, including hematologic malignancies

• performance status criterion of 0, 1, or 2 \[ with 0 indicating that the patient is asymptomatic, 1 that the patient is symptomatic but fully ambulatory, and 2 that the patient is symptomatic and in bed \<50% of the day\]

Locations
United States
Massachusetts
Dana Farber Cancer Institute
RECRUITING
Boston
Contact Information
Primary
Miryam Yusufov, PhD
miryam_yusufov@dfci.harvard.edu
(617) 582-7618
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 40
Treatments
Other: INTERVENTION FOR AVOIDANCE-RELATED OPIOID MISUSE
Participants will participate in a six-session behavioral intervention, delivered by a licensed clinical psychologist.
Related Therapeutic Areas
Sponsors
Leads: Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov